Understand the source comparison
Do Peptides Help with Telomere Lengthening vs Telomere Preservation Comparison
Direct telomerase activation (hTERT upregulation) Epitalon Animal models + small observational human trials 5–7% elongation in vitro; unconfirmed in vivo Theoretically elevated (parallels oncogenic telomerase reactivation) Strongest mechanistic candidate but l
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Direct telomerase activation (hTERT upregulation)
- Epitalon
- Animal models + small observational human trials
- 5–7% elongation in vitro; unconfirmed in vivo
- Theoretically elevated (parallels oncogenic telomerase reactivation)
- Strongest mechanistic candidate but lacks Phase III human validation and safety profile
- Oxidative stress reduction (indirect preservation)
- Thymalin
- Preclinical + 1 small human trial
- 4.3% increase in lymphocyte telomere length (may reflect T-cell population shift)
- Minimal. No direct proliferative signaling
- Plausible indirect mechanism; effect size within assay noise margins
- DNA repair enhancement
- Cartalax
- In vitro only
- Reduced oxidative telomere damage by 22%
- Minimal. Repair pathways are tumor-suppressive
- Mechanistically sound but zero human telomere data
- Growth hormone axis modulation
- MK 677
- Human trials for IGF-1 elevation; no telomere endpoints
- Indirect through improved cellular metabolism
- Unknown. Chronic IGF-1 elevation has mixed longevity signals
- No telomere-specific evidence; speculative benefit through metabolic optimization